Learn with Anil · APPSC Group-I PYQsPractise online →Subscribe ₹149
LVM3 lifting off with Chandrayaan-3 from Sriharikota, Andhra Pradesh

Photo: LVM3 launch, Sriharikota, ISRO, GODL-India

APPSC Group-I Mains 2025 · Paper V

2025 Paper V · Q9(a): model answer

Science, Technology & Environmental Issues · Biotechnology and health. Held in May 2025 (Notification 12/2023).

Q9(a)10 marks2025 · Paper V

Analyze the potential of plant-derived biopharmaceuticals in promoting sustainable healthcare. Explain how the application of green pharmacy principles can help minimize environmental harm at each stage of the pharmaceutical lifecycle.

Syllabus: Biotechnology and health · Biotechnology

Model answer · free

Plant-derived biopharmaceuticalsMolecular farmingGreen pharmacyPharmaceutical lifecycle

Plant-derived biopharmaceuticals are medicines taken from plants or produced inside them. They include classic plant drugs such as artemisinin and paclitaxel and, through molecular farming, therapeutic proteins, antibodies and vaccines made in genetically engineered plants or plant cells. Green pharmacy applies green chemistry and sustainability to every stage of a medicine's life, from design to disposal, so that curing people does not poison rivers, soils and wildlife.

1. Potential for sustainable healthcare

Therapeutic gene put into plant cells
Plants or cell cultures grown
Leaves or cells harvested
Protein extracted and purified
Tested and approved as a drug
Molecular farming: how a plant makes a medicine
  • Low cost, easy scale-up: plants need only light, water and nutrients; more greenhouse space replaces costly steel bioreactors and mammalian cell culture.
  • Safety: plants do not carry human or animal viruses and prions, a risk with mammalian cell lines.
  • Proven products: taliglucerase alfa, an enzyme for Gaucher disease made in carrot cells, became the first plant-made protein drug approved by the US FDA (2012); the ZMapp antibodies against Ebola (2014) were grown in tobacco leaves; Canada approved a plant-made COVID-19 vaccine, Covifenz, in 2022.
  • Renewable small molecules: plant-cell fermentation now makes the anticancer drug paclitaxel without felling slow-growing yew trees; artemisinin from Artemisia annua anchors malaria treatment.
  • Limits: low yields, costly purification, plant-type sugars on proteins, and gene flow from open-field GM crops, so contained greenhouses or cell cultures are preferred.

2. Green pharmacy at each stage of the lifecycle

StageEnvironmental harmGreen-pharmacy remedy
DesignPersistent molecules that stay in waterBenign-by-design, biodegradable molecules
Raw materialsOver-harvested wild herbs; fossil feedstocksCultivated, traceable plants; renewable feedstocks
ManufacturingToxic solvents; 25 to over 100 kg waste per kg of drugGreen chemistry, enzymes as catalysts, solvent recovery, clean energy
EffluentsAntibiotic residues that breed superbugsZero liquid discharge; residue limits
Packaging and distributionPlastic waste; energy-hungry cold chainRecyclable packs, efficient logistics
Use and disposalOveruse; drugs flushed or dumpedRational prescribing; take-back of expired medicines
Green pharmacy across the pharmaceutical lifecycle

3. Green-pharmacy principles in practice

  • Principles: waste prevention, atom economy, safer solvents, energy efficiency, renewable feedstocks and design for degradation (Anastas and Warner's twelve principles of green chemistry, 1998).
  • Lesson from vultures: the painkiller diclofenac in cattle carcasses wiped out more than 95% of India's Gyps vultures before its veterinary use was banned in 2006; drugs must also be judged for ecological safety.
  • Antibiotic pollution: effluents from bulk-drug clusters such as Patancheru (Telangana) were found to carry very high antibiotic levels; India's NAP-AMR 2.0 (2025–29) follows One Health, linking factory effluents to drug resistance.
  • Sustainable sourcing: good agricultural and collection practices, the National Medicinal Plants Board (2000) and benefit-sharing under the Biological Diversity Act, 2002 protect wild medicinal flora and collectors.

AP angle: Andhra Pradesh's bulk-drug belt around the Jawaharlal Nehru Pharma City, Parawada (Anakapalli) needs strict effluent treatment, solvent recovery and APPCB monitoring, while tribal collectors of medicinal plants in the Eastern Ghats need sustainable-harvest rules.

Plant-based production and green pharmacy together can deliver affordable, low-impact healthcare; India, a global generic-drug supplier, should pair molecular-farming research with binding effluent standards and drug take-back schemes.

The other choice in Q9

Answer either one in the exam.

  1. Q9(b)Differentiate between conventional and non-conventional energy resources. Explain their relevance in India's energy sector.

    10 marks · Energy: conventional and renewable · Energy: conventional sources and security

Write better answers: the Answer Writing Tool Kit

Every model answer on these pages is free to read. The Tool Kit adds four PDF books for Mains Papers I–IV: every previous question sorted by syllabus, with practice questions. It is in the ₹149 All-in-One Pass, with every previous paper of every exam on the site, practice quizzes, timed tests, mock test series and study books.

₹149 · valid for 12 months from the day you pay, on every exam · pay by UPI, card or net banking

Get it for ₹149